公司资料
Globus Medical 股价、新闻与催化剂
- 股票代码:
- GMED
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
85.12 USD (-0.91%)
收盘价
最后更新: 2026年8月17日
10.6B USD
市值
股价为何变动
As of Aug 17, 2026, GMED closed down 0.91% at $85.12. No new same-company headline was identified in the current news window.
公司概览
Musculoskeletal Technology
Globus Medical develops products and technologies for musculoskeletal care. Its portfolio covers spinal surgery, orthopedic trauma, joint reconstruction and neuromodulation.
Implants and Enabling Technologies
The company sells implants, instruments and biologics across spine, orthopedic trauma and joint-reconstruction procedures.
Enabling Technologies
Globus provides navigation, imaging and robotic systems that support surgical planning and execution. These technologies create a broader procedural ecosystem around its implant portfolio.
Expanded Pain-Management Platform
Through Nevro, Globus also participates in spinal-cord stimulation and other neuromodulation therapies for chronic pain, broadening the company beyond its traditional spine and orthopedic markets.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。